Abstract
Adenocarcinoma is now the dominant histological subtype of oesophageal cancer in high-income countries in Europe and North America. Patient outcomes have improved during the past few decades due to centralisation of surgery and implementation of multimodality therapy. However, most patients relapse following curative-intent surgery. Therefore, more effective perioperative treatment options are needed.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
